FindTrial
Sign In

The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance

The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029579
Enrollment
Unknown
Registered
2020-02-05
Start date
2020-01-31
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.No age restriction. 2. Clinically confirmed 2019-nCoV infected patients. 3. Patients with willingness and ability to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients without any clinical and chest radiographic findings. 2. Patients not providing written informed consent.

Design outcomes

Primary

MeasureTime frame
Cytokines;—

Countries

China

Contacts

Public ContactJianfeng Zhou

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

zhougene@medmail.com.cn+86 027-83665506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026